Why the study?
Does paclitaxel-coated balloon angioplasty improve 2-year clinical outcomes in selected patients presenting with STEMI compared to drug-eluting stents?
Does paclitaxel-coated balloon angioplasty improve 2-year clinical outcomes in selected patients presenting with STEMI compared to drug-eluting stents?
Answers are grounded in this paper and cite their sources.
In selected patients with STEMI, paclitaxel-coated balloon angioplasty demonstrated comparable 2-year clinical outcomes and safety to drug-eluting stents.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Niehe et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: